Investors Menu

SEC Filing Details

Document Details

Form
Filing Date
11/02/2020
Document Date
10/29/2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Eagle Pharmaceuticals, Inc.
Issuer
EAGLE PHARMACEUTICALS, INC.
Change % Volume Data as of 06/24/2022 10:11 PM EDT Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Contact

In-Site
Communications, Inc.
Lisa M. Wilson,
212-452-2793

For all other media inquiries, please contact us.